Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Olanzapine × 1 year × Clear all

Sponsor

Conditions

Neoplasms 5 Vomiting 3 Nausea 2 Anorexia 2 Weight Loss 1 Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Muscular Atrophy 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Gynecologic Cancer 1 Gliosarcoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Child Nutrition Disorders 1 Cachexia 1 Breast Neoplasms 1

Interventions

Cisplatin 7 Etoposide 6 fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Bleomycin 3 Automobiles 3 pralsetinib 2 pembrolizumab 2 etoposide phosphate 2 Sirolimus 2 Paclitaxel 2 Mesna 2 Drug Therapy 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 tozuleristide 1 sodium thiosulfate 1 repotrectinib 1 pegfilgrastim 1 lutetium Lu 177 dotatate 1 durvalumab 1 cabozantinib 1 Vorinostat 1 Teniposide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡